Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?
If you thought you were having a bad Monday, spare a thought for Actinogen Medical (ASX:ACW) shareholders who saw their…
Read More
Eli Lilly (NYSE:LLY): Is this US$700bn company the biggest threat to Novo Nordisk & Ozempic?
For investors who missed out on Novo Nordisk, or reckon it is overvalued, Eli Lilly (NYSE:LLY) could be the next…
Read More
Here are 4 family owned ASX companies to watch eagerly
Family owned ASX companies are a rare breed. We’re not talking about companies that are still founder-led, we’re talking about…
Read More